COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswamy, Swathi Beladakere, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369032/
https://www.ncbi.nlm.nih.gov/pubmed/32508329
http://dx.doi.org/10.3233/JND-200520
_version_ 1783560710177947648
author Ramaswamy, Swathi Beladakere
Govindarajan, Raghav
author_facet Ramaswamy, Swathi Beladakere
Govindarajan, Raghav
author_sort Ramaswamy, Swathi Beladakere
collection PubMed
description This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.
format Online
Article
Text
id pubmed-7369032
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-73690322020-07-22 COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome Ramaswamy, Swathi Beladakere Govindarajan, Raghav J Neuromuscul Dis Case Report This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient. IOS Press 2020-06-02 /pmc/articles/PMC7369032/ /pubmed/32508329 http://dx.doi.org/10.3233/JND-200520 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ramaswamy, Swathi Beladakere
Govindarajan, Raghav
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title_full COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title_fullStr COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title_full_unstemmed COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title_short COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
title_sort covid-19 in refractory myasthenia gravis- a case report of successful outcome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369032/
https://www.ncbi.nlm.nih.gov/pubmed/32508329
http://dx.doi.org/10.3233/JND-200520
work_keys_str_mv AT ramaswamyswathibeladakere covid19inrefractorymyastheniagravisacasereportofsuccessfuloutcome
AT govindarajanraghav covid19inrefractorymyastheniagravisacasereportofsuccessfuloutcome

Ejemplares similares